04-Nov-2026 13:27:42
SMSPHARMAGeneral news
SMSPHARMA Q2 : CONS NET PROFIT UP 57.4% AT ₹39.85 CR (YOY), UP 90.6% (QOQ). STRONG (On 1st Look)
Revenue up 30.4% at ₹316.09 Cr (YOY), up 52.7% (QOQ). Ebitda up 38.5% at ₹68.99 Cr (YOY); margins 21.8% v 20.5% (YOY), 20.6% (QOQ). Net profit after tax and share of associate profit at ₹39.85 Cr; associate share ₹0.28 Cr for the quarter. EPS ₹4.26 v ₹2.84 (YOY); no exceptional items reported.
SMS Pharmaceuticals Limited
Open attachment